Published in J Nutr on March 31, 2010
Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol (2012) 1.17
Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones. Mutat Res (2011) 0.95
Location, location, location: genetic regulation of neural sex differences. Rev Endocr Metab Disord (2012) 0.81
Improved human visuomotor performance and pupil constriction after choline supplementation in a placebo-controlled double-blind study. Sci Rep (2015) 0.80
Acetyl-CoA the key factor for survival or death of cholinergic neurons in course of neurodegenerative diseases. Neurochem Res (2013) 0.79
Moderate Perinatal Choline Deficiency Elicits Altered Physiology and Metabolomic Profiles in the Piglet. PLoS One (2015) 0.78
Effects of Choline on Meat Quality and Intramuscular Fat in Intrauterine Growth Retardation Pigs. PLoS One (2015) 0.75
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study. Clin Res Hepatol Gastroenterol (2013) 1.70
Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ Res (2003) 1.64
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem (2007) 1.62
Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB J (2003) 1.61
Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research. Curr Med Chem (2006) 1.60
Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin. FASEB J (2003) 1.52
Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem (2009) 1.50
Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene (2002) 1.48
Esomeprazole-induced central fever with severe myalgia. Ann Pharmacother (2005) 1.41
Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol (2010) 1.35
Oxidative stress, mitochondrial bioenergetics, and cardiolipin in aging. Free Radic Biol Med (2010) 1.30
Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease. Cell Calcium (2009) 1.23
Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr (2006) 1.17
Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology (2008) 1.16
Ca2+-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: role of cardiolipin. J Biol Chem (2004) 1.15
Interaction of peroxidized cardiolipin with rat-heart mitochondrial membranes: induction of permeability transition and cytochrome c release. FEBS Lett (2006) 1.14
New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta (2009) 1.13
Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all. J Hepatol (2009) 1.12
Mitochondrial complex I dysfunction in rat heart with aging: critical role of reactive oxygen species and cardiolipin. Free Radic Biol Med (2008) 1.10
Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer. World J Gastroenterol (2003) 1.09
Mitochondrial dysfunction in brain aging: role of oxidative stress and cardiolipin. Neurochem Int (2011) 1.08
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med (2012) 1.07
Carvedilol inhibits mitochondrial complex I and induces resistance to H2O2 -mediated oxidative insult in H9C2 myocardial cells. Biochim Biophys Acta (2007) 1.06
Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. Biochim Biophys Acta (2007) 1.05
The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. J Surg Res (2005) 1.05
Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res (2010) 1.04
Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin Biochem (2005) 1.03
Role of mitochondria in nonalcoholic fatty liver disease--from origin to propagation. Clin Biochem (2012) 1.03
Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res (2005) 1.00
Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition and cytochrome c release. Free Radic Biol Med (2009) 0.99
Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol (2013) 0.99
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α. J Neuroinflammation (2012) 0.98
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement. PLoS One (2011) 0.97
Molecular pathophysiology and physical chemistry of cholesterol gallstones. Front Biosci (2008) 0.97
Dissecting the genetic heterogeneity of gallbladder stone formation. Semin Liver Dis (2011) 0.97
Genetic factors involved in the effects of developmental low-level alcohol induced behavioral alterations in rats. Neuropsychopharmacology (2002) 0.96
The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa. PLoS One (2009) 0.96
PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease. Semin Liver Dis (2013) 0.96
Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease. Biochim Biophys Acta (2011) 0.96
Biochemical mechanisms in drug-induced liver injury: certainties and doubts. World J Gastroenterol (2009) 0.95
Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity? Toxicology (2004) 0.94
Tight control of mitochondrial membrane potential by cytochrome c oxidase. Mitochondrion (2010) 0.94
Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts. Clin Biochem (2007) 0.94
Present and future therapeutic strategies in non-alcoholic fatty liver disease. Expert Opin Ther Targets (2007) 0.94
Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice. Biochim Biophys Acta (2009) 0.93
Steatosis in the liver. Compr Physiol (2013) 0.93
Mitochondria in chronic liver disease. Curr Drug Targets (2011) 0.93
Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician (2007) 0.93
Ceramide induces release of pro-apoptotic proteins from mitochondria by either a Ca2+ -dependent or a Ca2+ -independent mechanism. J Bioenerg Biomembr (2004) 0.93
Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage. J Hepatol (2002) 0.93
Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol (2009) 0.92
Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine. Free Radic Biol Med (2005) 0.92
Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond) (2006) 0.91
Long-term functional assessment of antegrade colonic enema for combined incontinence and constipation using a modified Marsh and Kiff technique. Dis Colon Rectum (2007) 0.90
Current pharmacological treatment of nonalcoholic fatty liver. Curr Med Chem (2006) 0.90
Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease. J Lipids (2011) 0.90
Lipidomics of intact mitochondria by MALDI-TOF/MS. J Lipid Res (2012) 0.90
Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am (2010) 0.90
Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature. Endocrinology (2008) 0.90
Management of liver cirrhosis between primary care and specialists. World J Gastroenterol (2011) 0.89
Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia. Clin Pharmacol Ther (2005) 0.89
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage. Dig Liver Dis (2009) 0.89
Increased susceptibility to Ca(2+)-induced permeability transition and to cytochrome c release in rat heart mitochondria with aging: effect of melatonin. J Pineal Res (2010) 0.88
Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. Psychopharmacology (Berl) (2008) 0.88
Does mediastinal extension of the goiter increase morbidity of total thyroidectomy? A multicenter study of 19,662 patients. Ann Surg Oncol (2011) 0.88
Old and new antirheumatic drugs and the risk of hepatotoxicity. Ther Drug Monit (2012) 0.87
Total thyroidectomy is improved by loupe magnification. Microsurgery (2004) 0.87
Non-alcoholic fatty liver disease in the metabolic syndrome. Curr Pharm Des (2007) 0.87
A pleiotropic role for the orphan nuclear receptor small heterodimer partner in lipid homeostasis and metabolic pathways. J Lipids (2012) 0.87
Avoiding drug interactions: here's help. J Fam Pract (2010) 0.87
Contractility in vitro and mitochondrial response in small and large rabbit bowel after anastomosis. World J Surg (2002) 0.87
MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment. J Gastrointestin Liver Dis (2013) 0.87
Changes in the mitochondrial permeability transition pore in aging and age-associated diseases. Mech Ageing Dev (2012) 0.86
Lith genes and genetic analysis of cholesterol gallstone formation. Gastroenterol Clin North Am (2010) 0.86
Contribution of canalicular glutathione efflux to bile formation. From cholestasis associated alterations to pharmacological intervention to modify bile flow. Curr Drug Targets Immune Endocr Metabol Disord (2005) 0.86
Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection? J Lipids (2012) 0.85
New insights into the molecular mechanism of intestinal fatty acid absorption. Eur J Clin Invest (2013) 0.85
Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol. Eur J Clin Invest (2013) 0.85
Developmental omega-3 supplementation improves motor skills in juvenile-adult rats. Int J Dev Neurosci (2009) 0.84
Cognitive and neural determinants of response strategy in the dual-solution plus-maze task. Learn Mem (2011) 0.84
Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: results from humans and cholestatic rats. Hepatology (2007) 0.84
Cardiolipin and mitochondrial function in health and disease. Antioxid Redox Signal (2014) 0.84
Decline in cytochrome c oxidase activity in rat-brain mitochondria with aging. Role of peroxidized cardiolipin and beneficial effect of melatonin. J Bioenerg Biomembr (2013) 0.83
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study. Ann Hepatol (2013) 0.83
X-Ray absorption studies of Zn2+ binding sites in bacterial, avian, and bovine cytochrome bc1 complexes. Biophys J (2007) 0.83
Transverse leukonychia in severe hypocalcemia. Eur J Dermatol (2004) 0.83
Altered expression and distribution of aquaporin-9 in the liver of rat with obstructive extrahepatic cholestasis. Am J Physiol Gastrointest Liver Physiol (2008) 0.83